Medtronic Offsets VBP with Strength in U.S.

Medtronic reported FY 2Q23 orthopedic sales of $827.4 million, +6.4% compared to the second quarter of FY 2022.

While the company experienced slower-than-expected recovery and supply constraints in some of its businesses, its spine franchise grew in the mid-teens in the U.S. Those gains offset volume-based procurement in China and currency...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us